logo

TODAY'S TOP STORIES

Share

inmunebio-041719.jpg Shares of INmune Bio Inc. (INMB) touched an all-time high of $11 on Tuesday (Apr.16), and that represents a gain of nearly 38% since their market debut in February.

wallstreet1-061518_18apr19.jpg Extending the lackluster performance seen in the previous session, stocks continued to show a lack of direction over the course of the trading day on Thursday. The major averages once again spent the day bouncing back and forth across the unchanged line.

trump6-sept_18apr19.jpg Repeating language he has used throughout the investigation, President Donald Trump declared victory Thursday following the release of special counsel Robert Mueller's report on Russian interference in the 2016 presidential election. "No collusion, no obstruction," Trump said.

wallstreet-oct29_18apr19.jpg Following the lackluster performance seen in the previous session, stocks have continued to experience choppy trading on Thursday. The major averages have once again spent the day bouncing back and forth across the unchanged line.

wallstreet-sept06_18apr19.jpg Upbeat economic data contributed to initial strength on Wall Street, although buying interest waned shortly after the start of trading. The major averages have subsequently pulled back well off their early highs, with the Nasdaq and the S&P 500 sliding into negative territory.

leading-index-041819.jpg A report released by the Conference Board on Thursday showed its reading on U.S. leading economic indicators rose by slightly more than anticipated in the month of March. The Conference Board said its leading economic index climbed by 0.4 percent.

businessinventories-041819.jpg Business inventories in the U.S. increased by slightly less than anticipated in the month of February, according to a report released by the Commerce Department on Thursday.

phillyfed-index-041819.jpg A report released by the Federal Reserve Bank of Philadelphia on Thursday showed the pace of growth in regional manufacturing activity slowed by more than anticipated in the month of April following a significant rebound in the previous month.

retailsales-041819.jpg Retail sales in the U.S. spiked by much more than expected in the month of March, the Commerce Department revealed in a report released on Thursday. The Commerce Department said retail sales soared by 1.6 percent in March after dipping by 0.2 percent in February.

joblessclaims-041819.jpg First-time claims for U.S. unemployment benefits unexpectedly edged lower in the week ended April 13th, according to a report released by the Labor Department on Thursday, with jobless claims falling to a nearly 50-year low. The report said initial jobless claims dipped to 192,000.

wallstreet-sept19_18apr19.jpg After ending the previous session slightly lower, stocks may move back to the upside in early trading on Thursday. The major index futures are currently pointing to a modestly higher open for the markets, with the Dow futures up by 26 points.

wallstreet-april18.jpg Jobless Claims for the week, Retail Sales Report as well as Flash Composite Purchasing Managers' Index are the highlights on Thursday. The market is low ahead of the long weekend. Initial trading on U.S. Futures Index suggest that Wall Street might be opening lower. Asian shares finished mostly...

pigs-april18.jpg The conventional wisdom is that if the brain cells of humans and other mammals are deprived of oxygen for 4-5 min, they begin to die, and that the loss of brain functions after death is irreversible. But the findings of a study conducted by Yale University researchers challenge these long-held assumptions.

stockmarkets-aug17_18apr19.jpg European stocks were trading mixed on Thursday as investors adopted a cautious stance before the Easter weekend. Most European markets will remain closed on Friday and Monday for the Easter holiday. Meanwhile, the latest economic reports proved to be a mixed bag. While U.K. retail sales volumes...

bubbleboy-april18.jpg Shares of Mustang Bio Inc. (MBIO) soared more than 349 percent to $11.96 in extended trading on Wednesday, following encouraging results of the company's MB-107, an investigational lentiviral gene therapy for the treatment of bubble boy disease.

Follow RTT